Jiun-I Lai

7PUBLICATIONS
47CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 30, 2022
IKZF3 amplification frequently occurs in HER2-positive breast cancer and is a potential therapeutic target.

Chih-Yi Lin, Chung-Jen Yu, Chia-I Shen

|Sep 10, 2022
Correction to: CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu

|Aug 02, 2022
CDK4/6 inhibitors downregulate the ubiquitin-conjugating enzymes UBE2C/S/T involved in the ubiquitin-proteasome pathway in ER + breast cancer.

Chih-Yi Lin, Chung-Jen Yu, Chun-Yu Liu

Pageof 2